U.S. Court of Appeals for the Eleventh Circuit, 2013

FTC v. Watson Pharmaceuticals, Inc.

FTC v. Watson Pharmaceuticals, Inc.
U.S. Court of Appeals for the Eleventh Circuit · Decided September 9, 2013

FTC v. Watson Pharmaceuticals, Inc.

Opinion

Case: 10-12729 Date Filed: 09/09/2013 Page: 1 of 2

[DO NOT PUBLISH]

IN THE UNITED STATES COURT OF APPEALS FOR THE ELEVENTH CIRCUIT ________________________ No. 10-12729 ________________________ D.C. Docket No. 1:09-cv-00955-TWT

FEDERAL TRADE COMMISSION, Plaintiff -Counter Defendant- Appellant, versus WATSON PHARMACEUTICALS, INC., SOLVAY PHARMACEUTICALS, INC., Defendants - Appellees, PAR PHARMACEUTICAL COMPANIES, INC., PADDOCK LABORATORIES, INC., Defendants-Counter Claimants-Appellees.

________________________ Appeal from the United States District Court for the Northern District of Georgia ________________________ (September 9, 2013) Case: 10-12729 Date Filed: 09/09/2013 Page: 2 of 2

ON REMAND FROM THE SUPREME COURT OF THE UNITED STATES Before CARNES, Chief Judge, KRAVITCH and FARRIS, * Circuit Judges.

PER CURIAM: The district court’s judgment, which was entered on April 21, 2010, is VACATED, and this case is REMANDED for further proceedings consistent with the Supreme Court’s opinion in F.T.C. v. Actavis, Inc., — U.S. —, 133 S.Ct. 2223 (2013).

* Honorable Jerome Farris, United States Circuit Judge for the Ninth Circuit, sitting by designation.

Case-law data current through December 31, 2025. Source: CourtListener bulk data.